Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC997230139;30140;30141 chr2:178704558;178704557;178704556chr2:179569285;179569284;179569283
N2AB965529188;29189;29190 chr2:178704558;178704557;178704556chr2:179569285;179569284;179569283
N2A872826407;26408;26409 chr2:178704558;178704557;178704556chr2:179569285;179569284;179569283
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: CGA
  • RefSeq wild type template codon: GCT
  • Domain: Ig-84
  • Domain position: 73
  • Structural Position: 155
  • Q(SASA): 0.2131
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/P None None 0.999 None 0.737 0.422 0.361360026772 gnomAD-4.0.0 6.84408E-07 None None None None N None 2.98757E-05 0 None 0 0 None 0 0 0 0 0
R/Q rs752814410 -1.226 0.999 None 0.611 0.333 0.223847106136 gnomAD-4.0.0 3.42205E-06 None None None None N None 0 0 None 0 2.51953E-05 None 0 1.7337E-04 2.6989E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.9967 likely_pathogenic 0.9956 pathogenic -2.196 Highly Destabilizing 0.923 D 0.649 neutral None None None None N
R/C 0.9755 likely_pathogenic 0.9514 pathogenic -2.211 Highly Destabilizing 1.0 D 0.741 deleterious None None None None N
R/D 0.9988 likely_pathogenic 0.9986 pathogenic -0.909 Destabilizing 0.995 D 0.681 prob.neutral None None None None N
R/E 0.9914 likely_pathogenic 0.9876 pathogenic -0.719 Destabilizing 0.983 D 0.579 neutral None None None None N
R/F 0.9953 likely_pathogenic 0.9943 pathogenic -1.687 Destabilizing 0.999 D 0.772 deleterious None None None None N
R/G 0.9946 likely_pathogenic 0.9933 pathogenic -2.507 Highly Destabilizing 0.991 D 0.616 neutral None None None None N
R/H 0.9187 likely_pathogenic 0.8831 pathogenic -2.369 Highly Destabilizing 0.999 D 0.627 neutral None None None None N
R/I 0.9756 likely_pathogenic 0.9676 pathogenic -1.3 Destabilizing 0.998 D 0.766 deleterious None None None None N
R/K 0.8807 likely_pathogenic 0.8766 pathogenic -1.625 Destabilizing 0.96 D 0.603 neutral None None None None N
R/L 0.9713 likely_pathogenic 0.962 pathogenic -1.3 Destabilizing 0.991 D 0.631 neutral None None None None N
R/M 0.9927 likely_pathogenic 0.9899 pathogenic -1.725 Destabilizing 1.0 D 0.685 prob.neutral None None None None N
R/N 0.9973 likely_pathogenic 0.9969 pathogenic -1.377 Destabilizing 0.983 D 0.569 neutral None None None None N
R/P 0.9991 likely_pathogenic 0.9989 pathogenic -1.588 Destabilizing 0.999 D 0.737 prob.delet. None None None None N
R/Q 0.9166 likely_pathogenic 0.8661 pathogenic -1.392 Destabilizing 0.999 D 0.611 neutral None None None None N
R/S 0.9962 likely_pathogenic 0.9953 pathogenic -2.385 Highly Destabilizing 0.437 N 0.472 neutral None None None None N
R/T 0.9921 likely_pathogenic 0.9906 pathogenic -1.991 Destabilizing 0.967 D 0.614 neutral None None None None N
R/V 0.9834 likely_pathogenic 0.979 pathogenic -1.588 Destabilizing 0.995 D 0.757 deleterious None None None None N
R/W 0.9621 likely_pathogenic 0.9386 pathogenic -1.147 Destabilizing 1.0 D 0.705 prob.neutral None None None None N
R/Y 0.9879 likely_pathogenic 0.9853 pathogenic -0.992 Destabilizing 0.999 D 0.749 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.